185 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting Novel mHealth Platform to Ensure Quality of Community-based Malaria Diagnosis
Condition: Quality Assurance of Malaria Diagnosis
Intervention: Device: mHealth platform employing Fionet Deki Readers to ensure quality of community-based malaria diagnosis
22 Recruiting Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
Conditions: Chagas Disease;   Trypanosomiasis, South American;   South American Trypanosomiasis;   Disease, Chagas
Interventions: Drug: Fexinidazole;   Drug: Placebo
23 Recruiting To Evaluate the Efficacy of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria
Condition: Plasmodium Falciparum Infection
Interventions: Drug: Ferroquine SSR97193;   Drug: Artefenomel
24 Not yet recruiting Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria
Condition: Malaria
Interventions: Drug: Intrarectal artesunate;   Drug: Intravenous artesunate;   Drug: Intravenous quinine
25 Not yet recruiting A Comparison of Diagnostic Approaches for Malaria and Pneumonia
Conditions: Malaria;   Pneumonia
Intervention: Other: malaria or pneumonia diagnosis
26 Recruiting Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates
Condition: Malaria
Intervention:
27 Not yet recruiting Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar
Conditions: Uncomplicated Falciparum Malaria;   Artemisinin-resistant
Interventions: Drug: Arterolane maleate-piperaquine phosphate (Synriam);   Drug: Dihydroartemisinin-piperaquine phosphate (Duocotexin)
28 Recruiting A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)
Conditions: Malaria, Falciparum;   Drug Resistance
Interventions: Drug: ACT;   Drug: TACT
29 Not yet recruiting DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria
Condition: Falciparum Malaria
Interventions: Drug: DSM265 400mg;   Drug: Placebo to DSM265 400 mg;   Biological: Plasmodium falciparum sporozoite challenge;   Drug: Malarone
30 Recruiting Safety and Tolerability of Low Dose Primaquine
Conditions: Malaria, Falciparum;   G6PD Deficiency
Interventions: Drug: Dihydroartemisinin piperaquine (DHA PP);   Drug: Primaquine
31 Not yet recruiting Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
32 Recruiting Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
Condition: Visceral Leishmaniasis
Intervention: Drug: Miltefosine
33 Not yet recruiting Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
34 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition: Leishmaniasis
Intervention: Drug: Miltefosine
35 Not yet recruiting Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers
Conditions: P. Falciparum Malaria;   P. Falciparum Malaria Mixed Infection
Intervention:
36 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
Condition: Leishmaniasis or Other Uses of Miltefosine
Intervention: Drug: Miltefosine
37 Not yet recruiting Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria
Condition: Malaria
Interventions: Drug: Pyronaridine-artesunate;   Drug: Artemether-lumefantrine combination
38 Not yet recruiting Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)
Condition: Malaria
Interventions: Device: Spatial Repellent product with active ingredient (SHIELD);   Device: Active Ingredient;   Device: Spatial Repellent product without active ingredient (SHIELD)
39 Not yet recruiting Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence
Condition: Malaria
Intervention: Biological: Fourstar® granule, 90 day and 180 day briquettes Bti/Bs
40 Recruiting Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria
Condition: Malaria, Falciparum
Intervention: Drug: Pyronaridine-artesunate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years